Peer Review History

Original SubmissionJanuary 11, 2022
Decision Letter - Vanessa Carels, Editor

PONE-D-22-00962

Cancer patients’ experiences of the diagnosis and treatment of incidental pulmonary embolism

PLOS ONE

Dear Dr. Ben Elhaj,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible. 

Please submit your revised manuscript by Sep 17 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Vanessa Carels

Staff Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf".

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: An interesting piece of qualitative research, which adds to the current body of literature. The article is well structured, appropriate methodology, outcomes supported by appropriate quotes. On the whole the article is easy to read and follow. I do however have a few suggestions questions which I hope once addressed will make the artcile easier to follow.

Paragraph below (page 8) does not read well, difficult to make sense of it.

137 Although the diagnosis of pulmonary embolism was an incidental finding discovered on a CT scan ordered for cancer staging or follow up, participants reported having thrombosis (PE/DVT) related symptoms even though these had not been recognised where carers were present and willing to participate, dyad interviews were conducted.

Re quote below – this may be correct but need to check did the respondent say ‘wrap gloves’

198 “Just need to be careful, if I am going anywhere, and I wrap gloves if I work in the garden.”

What information do you present to support this statement below - in capturing information on the 11 patients interviewed did you ask about symptoms of PE? To enable you to state those without symptoms seemed to fare better?

260 Those without symptoms seemed to fare better psychologically, assuming “asymptomatic” to be “less dangerous”.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Nicola Jane Frances Pease

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Vanessa Carels,

Thank you for the opportunity to respond to the editor comments. We have addressed them point by point as described below. We think this has improved the quality of the review paper.

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf".

Thank you. We have checked all the requirements and made the amended the files names.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Thank you. We have checked the reference list and made the necessary amendments.

Reviewer #1: An interesting piece of qualitative research, which adds to the current body of literature. The article is well structured, appropriate methodology, outcomes supported by appropriate quotes. On the whole the article is easy to read and follow. I do however have a few suggestions questions which I hope once addressed will make the article easier to follow.

Thank you.

• Paragraph below (page 8) does not read well, difficult to make sense of it.

137 Although the diagnosis of pulmonary embolism was an incidental finding discovered on a CT scan ordered for cancer staging or follow up, participants reported having thrombosis (PE/DVT) related symptoms even though these had not been recognised. where carers were present and willing to participate, dyad interviews were conducted.

Thank you for pointing out this omission. We have amended this omission.

• Re quote below – this may be correct but need to check did the respondent say ‘wrap gloves’

198 “Just need to be careful, if I am going anywhere, and I wrap gloves if I work in the garden.”

Thank you for pointing out this omission. This now has been amended.

• What information do you present to support this statement below - in capturing information on the 11 patients interviewed did you ask about symptoms of PE? To enable you to state those without symptoms seemed to fare better?

260 Those without symptoms seemed to fare better psychologically, assuming “asymptomatic” to be “less dangerous”.

Thank you for raising this question. Patients were asked about their life with cancer before the diagnosis of IPE, which includes any new or worsening symptoms. We have this information mentioned in the analysis, Theme one: 137-141 “highlighted”. As well in Theme two: 175, 176 “highlighted”.

Thank you.

Attachments
Attachment
Submitted filename: Responce to the reviewers.docx
Decision Letter - Yoshihiro Fukumoto, Editor

PONE-D-22-00962R1Cancer patients’ experiences of the diagnosis and treatment of incidental pulmonary embolismPLOS ONE

Dear Dr. Ben Elhaj,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 16 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yoshihiro Fukumoto

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: I Don't Know

Reviewer #3: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: This study was a qualitative research regarding with cancer patients’ experience of the diagnosis and treatment of IPE. Although this study addresses interesting issue, there are some drawbacks in the manuscript as described below;

1. This study was a single center study with a small number of patients. How have the authors estimate the required number of subjects for this qualitative research?

2. Why did the authors choose qualitative study to explore cancer patients’ experience of the diagnosis and treatment of IPE? Please mention the reason it was difficult to explore this issue by quantitative research.

Reviewer #3: First of all, the current new Reviewer (for revision) would like to congratulate the authors for the current interesting report. The authors seemed to revise the manuscript appropriately according to the previous initial review. The Reviewer do not have a major comment and would like to raise a few minor comments for hope to be helpful for the authors before publication.

Minor comments)

Title: The current study was “a qualitative study”, not a quantitative study. For general readers, it could be helpful to describe “a qualitative study” in the title.

Results: In the study period, how many potential patients were there? (All IPE patients) 13? If possible, please add the information, because this information could show readers the absence or presence of selection bias of patients.

In Conclusions section, the authors described that “Routine education for patients and clinicians should be provided.” However, as a clear message for general readers, routine education seemed to be vague description. What did the authors would like to intend?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: Yes: Yugo Yamashita

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Reviewer #2: This study was a qualitative research regarding with cancer patients’ experience of the diagnosis and treatment of IPE. Although this study addresses interesting issue, there are some drawbacks in the manuscript as described below;

1. This study was a single center study with a small number of patients. How have the authors estimate the required number of subjects for this qualitative research?

Thank you for raising this question.

This was a convenience sample of consenting participants completing an observational survey study. (Line 78/79 highlighted). We adopt the theoretical saturation concept in this qualitative study (the point at which the data collection process no longer offers any new or relevant data) (line 95 highlighted and referenced). This is because qualitative research methods are often concerned with an in-depth understanding of a phenomenon or are focused on meaning (and heterogeneities in meaning)—which are often centred on the how and why of a particular issue, process, situation, subculture, scene or set of social interactions.

2. Why did the authors choose qualitative study to explore cancer patients’ experience of the diagnosis and treatment of IPE? Please mention the reason it was difficult to explore this issue by quantitative research.

Thank you for raising this question.

The objective of this study was to explore cancer patients’ experience of the diagnosis of and living with incidental pulmonary embolism treated with anticoagulation. (Line 20/21 highlighted) and statistical procedures and numeric data were insufficient to capture how patients feel about their diagnosis and its effects on their daily life.

The aim of this qualitative research is to understand the social reality of individuals cultures as nearly as possible as its participants feel it or live it, rather than make statistical inferences. This involves asking participants about their experiences of things that happen in their lives. It enables researchers to obtain insights into what it feels like to be another person and to understand the world as another experience it, whereas quantitative research may not provide definitive answers to such complex questions.

Reviewer #3: First of all, the current new Reviewer (for revision) would like to congratulate the authors for the current interesting report. The authors seemed to revise the manuscript appropriately according to the previous initial review. The Reviewer do not have a major comment and would like to raise a few minor comments for hope to be helpful for the authors before publication.

Thank you.

Minor comments)

Title: The current study was “a qualitative study”, not a quantitative study. For general readers, it could be helpful to describe “a qualitative study” in the title.

Thank you for pointing out this omission. We have amended this omission. (Title highlighted)

Results: In the study period, how many potential patients were there? (All IPE patients) 13? If possible, please add the information, because this information could show readers the absence or presence of selection bias of patients.

Thank you for raising this question.

Yes there were 13 potential patients. All been approached to participate. Two declined without giving any reason. (Line 79/80 highlighted).

In Conclusions section, the authors described that “Routine education for patients and clinicians should be provided.” However, as a clear message for general readers, routine education seemed to be vague description. What did the authors would like to intend?

Thank you for raising this question.

In the implications section of the paper, we referred to some potential ways that can be used to implement patients and health care education in patients’ care process, in the same way as patients are educated about neutropenic sepsis and spinal cord compression. (Line 312-317 highlighted).

However, we did not specify any potential actions of education as this need to be proved by future research, and this was out of the scope of this study.

Attachments
Attachment
Submitted filename: Responce to the revieweres.docx
Decision Letter - Yoshihiro Fukumoto, Editor

Cancer patients’ experiences of the diagnosis and treatment of incidental pulmonary embolism. (A Qualitative Study)

PONE-D-22-00962R2

Dear Dr. Ben Elhaj,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yoshihiro Fukumoto

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: I Don't Know

Reviewer #3: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

Reviewer #3: Thank you for your efforts of revision for the manuscript. The Reviewer do not have further comments. Congratulations for your important work.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: Yes: Yugo Yamashita

**********

Formally Accepted
Acceptance Letter - Yoshihiro Fukumoto, Editor

PONE-D-22-00962R2

Cancer patients’ experiences of the diagnosis and treatment of incidental pulmonary embolism (A Qualitative study)

Dear Dr. Benelhaj:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yoshihiro Fukumoto

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .